{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:14:13Z","timestamp":1790547253072,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K08-HL136839"],"award-info":[{"award-number":["K08-HL136839"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL149870"],"award-info":[{"award-number":["R01-HL149870"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009714","name":"Children's Cardiomyopathy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005295","name":"American Academy of Pediatrics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016228","name":"Derfner Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Pediatric Cardiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ppedcard.2021.101413","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:45:03Z","timestamp":1625100303000},"page":"101413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care"],"prefix":"10.1016","volume":"62","author":[{"given":"Lauren E.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Landstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ppedcard.2021.101413_bb0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ppedcard.2021.101413_bb0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.ppedcard.2021.101413_bb0025","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","article-title":"The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years","volume":"6","author":"Wilkinson","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0035","doi-asserted-by":"crossref","first-page":"e017731","DOI":"10.1161\/JAHA.120.017731","article-title":"Genetic causes of cardiomyopathy in children: first results from the pediatric cardiomyopathy genes study","author":"Ware","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacep.2015.08.004","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease","volume":"1","author":"ASJM","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"issue":"21","key":"10.1016\/j.ppedcard.2021.101413_bb0045","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.jacc.2017.09.1089","article-title":"Survival without cardiac transplantation among children with dilated cardiomyopathy","volume":"70","author":"Singh","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ppedcard.2021.101413_bb0050","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.jacc.2015.03.552","article-title":"Sudden death in childhood cardiomyopathy: results from a long-term national population-based study","volume":"65","author":"Bharucha","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cardfail.2015.06.381","article-title":"Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the pediatric cardiomyopathy registry","volume":"21","author":"Jefferies","year":"2015","journal-title":"J Card Fail"},{"issue":"21","key":"10.1016\/j.ppedcard.2021.101413_bb0060","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cardfail.2012.01.017","article-title":"Pediatric cardiomyopathy: importance of genetic and metabolic evaluation","volume":"18","author":"Kindel","year":"2012","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001666","article-title":"Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing","volume":"10","author":"Burns","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajmg.c.31764","article-title":"Investigation of de novo variation in pediatric cardiomyopathy","volume":"184","author":"Parrott","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ccr3.1920","article-title":"A 14-year-old in heart failure with multiple cardiomyopathy variants illustrates a role for signal-to-noise analysis in gene test re-interpretation","volume":"7","author":"Connell","year":"2019","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-a heart failure society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"issue":"39","key":"10.1016\/j.ppedcard.2021.101413_bb0095","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ppedcard.2021.101413_bb0100","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/oxfordjournals.aje.a009291","article-title":"Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland","volume":"146","author":"Arola","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jtcvs.2011.10.019","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0120","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"issue":"18","key":"10.1016\/j.ppedcard.2021.101413_bb0130","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","article-title":"Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy","volume":"2","author":"Kaski","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"14","key":"10.1016\/j.ppedcard.2021.101413_bb0150","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ppedcard.2021.101413_bb0155","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0165","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001768","article-title":"A comparison of whole genome sequencing to multigene panel testing in hypertrophic cardiomyopathy patients","volume":"10","author":"Cirino","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.20862","article-title":"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives","volume":"30","author":"Andersen","year":"2009","journal-title":"Hum Mutat"},{"issue":"45","key":"10.1016\/j.ppedcard.2021.101413_bb0190","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehz396","article-title":"Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?","volume":"40","author":"Lafreniere-Roula","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.118.038846","article-title":"Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives","volume":"140","author":"Norrish","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","article-title":"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy","volume":"101","author":"Lopes","year":"2015","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.ppedcard.2021.101413_bb0205","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.110.954446","article-title":"Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy","volume":"122","author":"Landstrom","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0210","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0002-9149(01)01532-6","article-title":"The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age","volume":"87","author":"Havndrup","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0220","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ejhf.144","article-title":"Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy","volume":"16","author":"Wang","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.ppedcard.2021.101413_bb0225","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ppedcard.2021.101413_bb0230","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0235","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yjmcc.2020.04.005","article-title":"Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes","volume":"142","author":"Tadros","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0240","article-title":"A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C","author":"Reinoso","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00246-008-9267-3","article-title":"Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease","volume":"29","author":"Levine","year":"2008","journal-title":"Pediatr Cardiol"},{"issue":"17","key":"10.1016\/j.ppedcard.2021.101413_bb0250","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6273","key":"10.1016\/j.ppedcard.2021.101413_bb0255","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"10253","key":"10.1016\/j.ppedcard.2021.101413_bb0260","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.ppedcard.2021.101413_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2017.02.008","article-title":"The design of the Valsartan for attenuating disease evolution in early sarcomeric hypertrophic cardiomyopathy (VANISH) trial","volume":"187","author":"Ho","year":"2017","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0270","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12265-014-9542-z","article-title":"Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise","volume":"7","author":"Kapplinger","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"issue":"23","key":"10.1016\/j.ppedcard.2021.101413_bb0275","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","article-title":"Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital mobility project on familial dilated cardiomyopathy","volume":"20","author":"Mestroni","year":"1999","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.ppedcard.2021.101413_bb0285","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0290","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1038\/s41598-019-44987-6","article-title":"Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy","volume":"9","author":"Jones","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0300","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajhg.2013.05.015","article-title":"Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy","volume":"93","author":"Arndt","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1747-0803.2011.00514.x","article-title":"Pathologic features of dilated cardiomyopathy with localized noncompaction in a child with deletion 1p36 syndrome","volume":"7","author":"Pearce","year":"2012","journal-title":"Congenit Heart Dis"},{"issue":"18","key":"10.1016\/j.ppedcard.2021.101413_bb0315","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"issue":"10092","key":"10.1016\/j.ppedcard.2021.101413_bb0320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0325","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1517\/21678707.2015.1057498","article-title":"Diagnosis, prevalence, and screening of familial dilated cardiomyopathy","volume":"3","author":"Sweet","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0330","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013346","article-title":"Prospective evaluation of the utility of whole exome sequencing in dilated cardiomyopathy","volume":"9","author":"Ramchand","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0335","article-title":"Diagnostic yield of whole exome sequencing in pediatric dilated cardiomyopathy","volume":"4","author":"Long","year":"2017","journal-title":"J Cardiovasc Dev Dis"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0340","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199201093260201","article-title":"The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy","volume":"326","author":"Michels","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0350","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Gr\u00fcnig","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0355","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ppedcard.2021.101413_bb0365","first-page":"458","article-title":"Heart failure in the era of precision medicine: a scientific statement from the American Heart Association","volume":"12","author":"Cresci","year":"2019","journal-title":"Circ Genomic Prec Med"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0370","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0375","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/emm.2007.13","article-title":"Lamin A\/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans","volume":"39","author":"Song","year":"2007","journal-title":"Exp Mol Med"},{"issue":"10","key":"10.1016\/j.ppedcard.2021.101413_bb0380","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121723","article-title":"Clinical and functional characterization of a novel mutation in Lamin a\/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy","volume":"10","author":"Forleo","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0390","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/heartjnl-2019-315942","article-title":"Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction","volume":"106","author":"Cannat\u00e0","year":"2020","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0395","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"22","key":"10.1016\/j.ppedcard.2021.101413_bb0400","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0405","doi-asserted-by":"crossref","first-page":"e005371","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","article-title":"Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0410","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ppedcard.2021.101413_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249599","article-title":"Small molecules acting on myofilaments as treatments for heart and skeletal muscle diseases","volume":"21","author":"Alsulami","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10062","key":"10.1016\/j.ppedcard.2021.101413_bb0420","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/S0140-6736(16)32049-9","article-title":"Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial","volume":"388","author":"Teerlink","year":"2016","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0425","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0430","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.00162.2016","article-title":"A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation","volume":"311","author":"Broughton","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"46","key":"10.1016\/j.ppedcard.2021.101413_bb0435","doi-asserted-by":"crossref","first-page":"17314","DOI":"10.1074\/jbc.RA119.010217","article-title":"Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil","volume":"294","author":"Tang","year":"2019","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0440","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/FJC.0000000000000286","article-title":"Omecamtiv mecarbil, a cardiac myosin activator, increases Ca2+ sensitivity in myofilaments with a dilated cardiomyopathy mutant tropomyosin E54K","volume":"66","author":"Utter","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"17","key":"10.1016\/j.ppedcard.2021.101413_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174098","article-title":"Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy","volume":"20","author":"Meyers","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.ppedcard.2021.101413_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145284","article-title":"Prevalence of titin truncating variants in general population","volume":"10","author":"Akinrinade","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0455","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrcardio.2017.190","article-title":"Role of titin in cardiomyopathy: from DNA variants to patient stratification","volume":"15","author":"Ware","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0460","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0465","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003131","article-title":"Amino acid-level signal-to-noise analysis aids in pathogenicity prediction of incidentally identified TTN-encoded titin truncating variants","volume":"14","author":"Connell","year":"2021","journal-title":"Circ Genomic Precis Med"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0470","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0475","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2019.05.022","article-title":"Phenotypic manifestations of arrhythmogenic cardiomyopathy in children and adolescents","volume":"74","author":"DeWitt","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0480","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.hlc.2018.03.023","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy: progress and pitfalls","volume":"27","author":"Oomen","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0485","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.hrthm.2013.11.006","article-title":"Sudden cardiac death in children and adolescents between 1 and 19 years of age","volume":"11","author":"Pilmer","year":"2014","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0490","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0495","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00246-018-1875-y","article-title":"Diagnosing ARVC in pediatric patients applying the revised task force criteria: importance of imaging, 12-Lead ECG, and genetics","volume":"39","author":"Steinmetz","year":"2018","journal-title":"Pediatr Cardiol"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0500","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ppedcard.2021.101413_bb0505","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jacc.2014.12.041","article-title":"Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents","volume":"65","author":"Etoom","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"9221","key":"10.1016\/j.ppedcard.2021.101413_bb0510","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"18","key":"10.1016\/j.ppedcard.2021.101413_bb0515","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0520","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGEN.120.003017","article-title":"Left-dominant Arrhythmogenic cardiomyopathy, palmoplantar keratoderma, and curly hair associated with a rare autosomal dominant truncating variant in desmoplakin","volume":"13","author":"Reza","year":"2020","journal-title":"Circ Genomic Precis Med"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0525","doi-asserted-by":"crossref","first-page":"e002800","DOI":"10.1161\/CIRCGEN.119.002800","article-title":"Early lethality due to a novel desmoplakin variant causing infantile epidermolysis bullosa simplex with fragile skin, aplasia cutis congenita, and arrhythmogenic cardiomyopathy","volume":"13","author":"Camors","year":"2020","journal-title":"Circ Genomic Precis Med"},{"issue":"23","key":"10.1016\/j.ppedcard.2021.101413_bb0530","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","article-title":"Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise","volume":"57","author":"Kapplinger","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0535","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","article-title":"Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies","volume":"14","author":"Sepehrkhouy","year":"2017","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0540","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"13","key":"10.1016\/j.ppedcard.2021.101413_bb0545","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0550","first-page":"e5381","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an updated review of diagnosis and management","volume":"11","author":"Sattar","year":"2019","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0555","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0004.2012.01950.x","article-title":"Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathy","volume":"83","author":"Roberts","year":"2013","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0560","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41431-018-0119-1","article-title":"Role of copy number variants in sudden cardiac death and related diseases: genetic analysis and translation into clinical practice","volume":"26","author":"Mates","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181840","article-title":"Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"12","author":"Fedida","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0570","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2009.11.020","article-title":"Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy","volume":"55","author":"Xu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"An international evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) using the ClinGen framework","author":"James","year":"2021","journal-title":"Circ Genomic Precis Med"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030162","article-title":"Rare variants associated with arrhythmogenic cardiomyopathy: reclassification five years later","volume":"11","author":"Vallverd\u00fa-Prats","year":"2021","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0585","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2006.06.045","article-title":"Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"48","author":"Dalal","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0590","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/europace\/euaa105","article-title":"Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients","volume":"22","author":"Wang","year":"2020","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.ppedcard.2021.101413_bb0595","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0600","doi-asserted-by":"crossref","first-page":"41387","DOI":"10.1038\/srep41387","article-title":"Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0605","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2019.01.065","article-title":"Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: genetic characteristics","volume":"286","author":"Vischer","year":"2019","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.ppedcard.2021.101413_bb0610","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehz172","article-title":"A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression","volume":"40","author":"Chen","year":"2019","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0615","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.hrthm.2020.02.028","article-title":"Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Paulin","year":"2020","journal-title":"Heart Rhythm"},{"issue":"14","key":"10.1016\/j.ppedcard.2021.101413_bb0620","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","article-title":"Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2","volume":"65","author":"Cruz","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0625","doi-asserted-by":"crossref","first-page":"e002579","DOI":"10.1161\/CIRCGEN.119.002579","article-title":"Prevalence and electronic health record-based phenotype of loss-of-function genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes","volume":"12","author":"Carruth","year":"2019","journal-title":"Circ Genomic Precis Med"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0630","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1002\/mgg3.593","article-title":"Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation","volume":"7","author":"Headrick","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0635","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4065\/72.1.26","article-title":"Isolated noncompaction of the myocardium in adults","volume":"72","author":"Ritter","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"10.1016\/j.ppedcard.2021.101413_bb0640","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2018.12.085","article-title":"Cardiac phenotypes, genetics, and risks in familial noncompaction cardiomyopathy","volume":"73","author":"van Waning","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0645","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/heart.86.6.666","article-title":"Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy","volume":"86","author":"Jenni","year":"2001","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0650","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0655","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001735","article-title":"Genetic testing in pediatric left ventricular noncompaction","volume":"10","author":"Miller","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0660","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, clinical features, and Long-term outcome of noncompaction cardiomyopathy","volume":"71","author":"van Waning","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0665","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymgme.2005.11.009","article-title":"Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity","volume":"88","author":"Xing","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.ppedcard.2021.101413_bb0670","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001763","article-title":"Novel genetic triggers and genotype-phenotype correlations in patients with left ventricular noncompaction","volume":"10","author":"Miszalski-Jamka","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0675","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijcard.2016.08.272","article-title":"Prominent left ventricular trabeculations in competitive athletes: a proposal for risk stratification and management","volume":"223","author":"Caselli","year":"2016","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.ppedcard.2021.101413_bb0680","doi-asserted-by":"crossref","first-page":"e012993","DOI":"10.1161\/JAHA.119.012993","article-title":"Systematic review of genotype-phenotype correlations in noncompaction cardiomyopathy","volume":"8","author":"van Waning","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"46","key":"10.1016\/j.ppedcard.2021.101413_bb0685","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/eurheartj\/ehx545","article-title":"Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy","volume":"38","author":"Sedaghat-Hamedani","year":"2017","journal-title":"Eur Heart J"},{"issue":"9995","key":"10.1016\/j.ppedcard.2021.101413_bb0690","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(14)61282-4","article-title":"Left ventricular non-compaction cardiomyopathy","volume":"386","author":"Towbin","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0695","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.ppedcard.2021.101413_bb0700","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"issue":"38","key":"10.1016\/j.ppedcard.2021.101413_bb0705","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0710","doi-asserted-by":"crossref","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0715","doi-asserted-by":"crossref","first-page":"e015111","DOI":"10.1161\/JAHA.119.015111","article-title":"Variant R94C","volume":"9","author":"Ezekian","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0720","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1542\/peds.2005-2301","article-title":"Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene","volume":"117","author":"Peddy","year":"2006","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ppedcard.2021.101413_bb0725","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/ajmg.a.37860","article-title":"Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy","volume":"170","author":"Ploski","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0730","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/humu.22942","article-title":"Mutations in FLNC are associated with familial restrictive cardiomyopathy","volume":"37","author":"Brodehl","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0735","doi-asserted-by":"crossref","first-page":"39276","DOI":"10.1038\/srep39276","article-title":"Molecular characterization of pediatric restrictive cardiomyopathy from integrative genomics","volume":"7","author":"Rindler","year":"2017","journal-title":"Sci Rep"},{"issue":"7726","key":"10.1016\/j.ppedcard.2021.101413_bb0740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ppedcard.2021.101413_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-018-0049-4","article-title":"Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization","volume":"3","author":"Farnaes","year":"2018","journal-title":"NPJ Genom Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0750","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41436-018-0044-2","article-title":"A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative","volume":"21","author":"Shashi","year":"2019","journal-title":"Genet Med"},{"issue":"Database issue","key":"10.1016\/j.ppedcard.2021.101413_bb0755","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.ppedcard.2021.101413_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203422","article-title":"Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure","volume":"13","author":"Vanninen","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0765","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10038-007-0149-y","article-title":"Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy","volume":"52","author":"Matsushita","year":"2007","journal-title":"J Hum Genet"},{"issue":"6","key":"10.1016\/j.ppedcard.2021.101413_bb0770","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.yjmcc.2007.04.006","article-title":"Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans","volume":"42","author":"Landstrom","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ppedcard.2021.101413_bb0775","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jnc.12217","article-title":"Cardiomyopathy of Friedreich ataxia","volume":"126","author":"Weidemann","year":"2013","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0780","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00392-018-1354-8","article-title":"Genetic basis of hypertrophic cardiomyopathy in children","volume":"108","author":"Rupp","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0785","doi-asserted-by":"crossref","first-page":"e002748","DOI":"10.1161\/CIRCGEN.119.002748","article-title":"Genetic testing for diagnosis of hypertrophic cardiomyopathy mimics: yield and clinical significance","volume":"13","author":"Hoss","year":"2020","journal-title":"Circ Genomic Precis Med"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0790","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCGENETICS.109.912345","article-title":"Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy","volume":"3","author":"Hershberger","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"8","key":"10.1016\/j.ppedcard.2021.101413_bb0795","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00431-019-03404-w","article-title":"Dilated cardiomyopathy in a national paediatric population","volume":"178","author":"Jammal Addin","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0800","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00246-017-1779-2","article-title":"Genetic testing in pediatric cardiomyopathy","volume":"39","author":"Ellepola","year":"2018","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0805","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12551-017-0265-7","article-title":"Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy","volume":"9","author":"Tabish","year":"2017","journal-title":"Biophys Rev"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0810","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cge.12741","article-title":"Relevance of truncating titin mutations in dilated cardiomyopathy","volume":"90","author":"Akinrinade","year":"2016","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.ppedcard.2021.101413_bb0815","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172995","article-title":"Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy","volume":"12","author":"Esslinger","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ppedcard.2021.101413_bb0820","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cge.12825","article-title":"Mutation in JPH2 cause dilated cardiomyopathy","volume":"90","author":"Sabater-Molina","year":"2016","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.ppedcard.2021.101413_bb0825","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001879","article-title":"Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-generation sequencing","volume":"4","author":"Wu","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ppedcard.2021.101413_bb0830","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1747-0803.2008.00165.x","article-title":"A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy","volume":"3","author":"Karam","year":"2008","journal-title":"Congenit Heart Dis"},{"issue":"1","key":"10.1016\/j.ppedcard.2021.101413_bb0835","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2013.11.037","article-title":"Titin mutation in familial restrictive cardiomyopathy","volume":"171","author":"Peled","year":"2014","journal-title":"Int J Cardiol"}],"container-title":["Progress in Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981321000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981321000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:18:31Z","timestamp":1778797111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1058981321000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":167,"alternative-id":["S1058981321000874"],"URL":"https:\/\/doi.org\/10.1016\/j.ppedcard.2021.101413","relation":{},"ISSN":["1058-9813"],"issn-type":[{"value":"1058-9813","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care","name":"articletitle","label":"Article Title"},{"value":"Progress in Pediatric Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ppedcard.2021.101413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101413"}}